category,datetime,headline,id,image,related,source,summary,url
company,1768934340,"Intuitive Surgical Pre-Q4 Analysis: Buy, Hold or Sell ISRG Stock Now?",138190370,https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png,BSX,Yahoo,"ISRG heads into Q4 earnings with 18% procedure growth and da Vinci 5 demand, but valuation and tariffs keep the earnings outlook uncertain.",https://finnhub.io/api/news?id=8fd01fc2f82b21e799795ec1243da0bbeaca51600a68448fb6a3518c1a020658
company,1768927020,Boston Scientific Corp. stock outperforms competitors on strong trading day,138209764,,BSX,MarketWatch,Boston Scientific Corp. stock outperforms competitors on strong trading day,https://finnhub.io/api/news?id=15d71f72033e1c2ec01d2419f2c03783b66e24c1b092657e084758aad6e9043c
company,1768916160,Should You Still Hold GMED Stock in Your Portfolio?,138187116,https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png,BSX,Yahoo,"Globus Medical is growing musculoskeletal market share with new product launches, strong finances and international expansion plans.",https://finnhub.io/api/news?id=8fcf6d4c60f993cacffa3956e6f6afe028aabf2e30b329af24eb3c14d64331c0
company,1768906353,3 takeaways from Boston Scientific’s $14.5B Penumbra deal,138187736,https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png,BSX,Yahoo,"Penumbra is expected to give Boston Scientific more of a presence in the vascular surgery market, with little overlap between the two companies’ products.",https://finnhub.io/api/news?id=b050939c9e6e7cac27695b0098e2a02d1472cd8240298b542087e8afe005088b
